MolecuLight ® Inc. Headquarters

MaRS Centre, South Tower
101 College Street,
Suite 200
Toronto, ON M5G 1L7
T. 647-362-4684
North American Toll Free
F. 647-362-4730

For more information contact us at:

About MolecuLight Inc

MolecuLight Inc. is a privately owned, Canadian medical imaging company delivering real-time fluorescence image-guidance solutions that provide clinicians with new information about wound bacterial burden and wound surface area to assist clinicians in making improved diagnostic and treatment decisions. The company was founded in 2012 by Dr. Ralph DaCosta, Principal Investigator and Scientist at the Princess Margaret Cancer Centre, University Health Network (Toronto, Canada), currently the company’s Chief Scientific Officer and Director. MolecuLight’s premiere product, the MolecuLight i:X, is a Wound Imaging Device that allows clinicians to quickly, safely and easily visualize bacteria that fluoresce in violet light and measure wound surface area at the point of care so they have maximum insights for accurate treatment selection and accelerated healing.